Glenmark gets USFDA nod for generic diabetes treatment drug
Shares of Glenmark Pharmaceuticals were trading at Rs 874.75 per scrip in afternoon trade, up 2.04 percent from the previous close on the BSE.
May 29, 2015, 12:49 PM IST
Generic Treatment Diabetes drugs